Clinical Trial Update: A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating TTI-101 as monotherapy and in combination for locally advanced or metastatic, unresectable hepatocellular carcinoma; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TTI-101

Snippet

Sponsor: Tvardi Therapeutics, Incorporated | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: RECRUITING